Tag Archives: Pfizer

The New York Times reports: After weeks of internal strife at the Food and Drug Administration, the agency on Wednesday authorized people over 65 who had received Pfizer-BioNTech’s coronavirus vaccine to get a booster shot at least six months after their second injection. The F.D.A. also authorized booster shots for adult Pfizer-BioNTech recipients who are at high risk of becoming …

USA Today reports: Pfizer is voluntarily recalling all lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the risk of cancer. According to the notice posted on the Food and Drug Administration website, the recall is for all lots of 0.5 mg and 1 mg varenicline tablets. The recall notice says that long-term ingestion …

The New York Times reports: The Pfizer-BioNtech coronavirus vaccine has been shown to be safe and highly effective in young children aged 5 to 11 years, the companies announced early Monday morning. The news should help ease months of anxiety among parents and teachers about when children, and their close contacts, might be shielded from the coronavirus. The need is …

The Guardian reports: The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have said. “Already over the next few weeks we will file the results of our trial in five- to 11-year-olds with regulators across the world and will request approval …

ABC News reports: Just prior to the announcement, the U.S. rate of first doses had stagnated. Although the country experienced an increase in people initiating vaccination in July as new coronavirus cases surged across the country, the average number of Americans getting their first dose had then declined. However, following Pfizer’s full approval, the U.S. saw a 17% increase in …

Posted to Franklin Graham’s Facebook page: Some good news on the vaccine front Pfizer received full FDA approval for their COVID-19 vaccine. Some people have expressed concern about only having emergency-use approval, so I hope this will relieve those concerns. I’m thankful for the doctors and scientists who have worked diligently to develop a vaccine that can help save lives …

The New York Times reports: The Food and Drug Administration on Monday granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and up, making it the first to move beyond emergency use status in the United States. The decision will set off a cascade of vaccine requirements by hospitals, colleges, corporations and other organizations. United Airlines recently announced that …

The Washington Post reports: Fresh data out of Israel is providing encouraging news about the effectiveness of coronavirus boosters in seniors. A study by the Israeli Health Ministry found that a third dose of the Pfizer-BioNTech vaccine provided four times as much protection against infection as two doses in people 60 and older. The level of protection was five to …

The New York Times reports: The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning. Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the …

Reuters reports: The United States Food and Drug Administration (FDA) is aiming to give full approval for the Pfizer Covid-19 vaccine by early September, the New York Times reported on Tuesday (Aug 3), citing people involved in the effort. The FDA gave emergency use authorization to the Pfizer vaccine late last year. Full approval by the FDA could push more …

The New York Post reports: The Pentagon announced Monday the US Army had awarded Pfizer a $3.5 billion contract to manufacture 500 million doses of its COVID-19 vaccine by the end of next year for distribution around the world. The order matches the number of Pfizer-BioNTech vaccine doses purchased by the US government under an agreement announced last year by …

The Hill reports: Two doses of the Pfizer COVID-19 vaccine are 88 percent effective against the delta variant, according to a new study. The study, published in the New England Journal of Medicine on Wednesday from researchers at Public Health England, offers reassurance about the effectiveness of the vaccines against the delta variant. The 88 percent effectiveness against the delta …

CNN reports: Pfizer and BioNTech said Friday that the US Food and Drug Administration has granted priority review designation to their application for full approval of their Covid-19 vaccine, and an FDA official said the decision will come “soon”. The FDA official told CNN on Friday that a decision on full approval is likely to come within two months. The …

Reuters reports: Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anti-competitive and unfair practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan. The proposed class action settlement was disclosed in a filing in federal court in Kansas City, Kansas. The deal, which …

CNN reports: Dr. Anthony Fauci, the country’s leading infectious disease expert, made clear today that if you have been fully vaccinated against Covid-19, there is no need for a booster shot. “The message is very clear, the CDC and the FDA say if you have been fully vaccinated at this point in time, you do not need a booster shot. …

NBC News reports: Pfizer is about to seek U.S. authorization for a third dose of its Covid-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant. Research from multiple countries shows the Pfizer shot and other widely used Covid-19 vaccines offer strong protection against the highly …

Reuters reports: COVID-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90% against hospitalisation from the Delta coronavirus variant, a new analysis by Public Health England (PHE) showed on Monday. PHE said that the Pfizer/Biontech COVID-19 vaccine was 96% effective against hospitalisation from the Delta variant after two doses, while Oxford/AstraZeneca’s offered 92% protection against hospitalisation …

The Wall Street Journal reports: President Biden’s administration plans to donate 500 million coronavirus vaccine doses produced by Pfizer Inc. to the rest of the world, according to people familiar with the plans. The administration expects 200 million of the Pfizer doses will go to other countries this year and 300 million across the first half of next year, one …

The Guardian reports: French and German YouTubers, bloggers and influencers have been offered money by a supposedly UK-based PR agency with apparent Russian connections to falsely tell their followers the Pfizer/BioNTech vaccine is responsible for hundreds of deaths. Fazze, which said it was an “influencer marketing platform … connecting bloggers and advertisers”, claimed to be based at 5 Percy Street …

Axios reports: The first Americans to be vaccinated against the coronavirus could require a third “booster” shot as early as September, the CEOs of Pfizer and Moderna told Axios. “The data that I see coming, they are supporting the notion that likely there will be a need for a booster somewhere between eight and 12 months,” Pfizer CEO Albert Bourla …